ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.17
      -0.25%
      US Tech 100
      19,288.80
      -0.62%
      Dow Jones
      39,134.76
      0.77%
      Brent Oil
      85.005
      0.37%
      Bitcoin
      64,821.94
      -0.22%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Tango Therapeutics Inc (TNGX) Quote

      Tango Therapeutics Inc

      Tango Therapeutics Inc (TNGX)

      9.55
      0.01
      (0.10%)
      At close: June 20 4:00PM
      Delayed by 15 minutes
      9.55
      0.00
      ( 0.00% )
      After Hours: 4:17PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      9.55
      Bid
      7.92
      Ask
      9.60
      Volume
      741,430
      9.36 Day's Range 9.80
      2.88 52 Week Range 13.03
      Market Cap
      974.002M
      Previous Close
      9.54
      Open
      9.69
      Last Trade
      12
      @
      9.57
      Last Trade Time
      16:25:33
      Financial Volume
      $ 7,107,146
      VWAP
      9.5857
      Average Volume (3m)
      597,291
      Shares Outstanding
      101,989,696
      Dividend Yield
      -
      PE Ratio
      -9.57
      Earnings Per Share (EPS)
      -1
      Revenue
      36.53M
      Net Profit
      -101.74M

      About Tango Therapeutics Inc

      Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.tangotx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was $9.54. Over the last year, Tango Therapeutics shares have traded in a share price range of $ 2.88 to $ 13.03.

      Tango Therapeutics currently has 101,989,696 shares outstanding. The market capitalization of Tango Therapeutics is $974 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -9.57.

      TNGX Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 06 2024
      Edgar (US Regulatory)

      Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

      Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

      June 05 2024
      Business Wire

      Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program

      Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program PR Newswire STOCKHOLM, May 23, 2024 STOCKHOLM, May 23, 2024 /PRNewswire/ -- Medivir AB (Nasdaq...

      May 23 2024
      PR Newswire (US)

      Form 8-K - Current report

      May 23 2024
      Edgar (US Regulatory)

      Tango Therapeutics Announces Discontinuation of TNG348 Program

      – The phase 1/2 clinical trial of TNG348, a USP1 inhibitor, is being terminated due to toxicity observed in the initial study cohorts – – Cash runway extended into 2027, PRMT5 and CoREST clinical...

      May 23 2024
      Business Wire

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 08 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1226.49006622527.559.87.4412394689.04738678CS
      42.8442.32488822656.719.86.467514147.75653504CS
      121.8423.86511024647.719.86.465972917.65753185CS
      26-0.67-6.5557729941310.2213.0056.466328309.29317964CS
      526.04172.079772083.5113.032.8810588498.38724956CS
      156-0.06-0.6243496357969.6118.842.475247288.01877964CS
      260-0.06-0.6243496357969.6118.842.475247288.01877964CS

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SPECSpectaire Holdings Inc
      $ 1.00
      (194.12%)
      		9.17M
      SRPTSarepta Therapeutics Inc New
      $ 166.25
      (34.62%)
      		866.25k
      BRNSBarinthus Biotherapeutics PLC
      $ 1.51
      (20.80%)
      		3.26k
      KTRAKintara Therapeutics Inc
      $ 0.32
      (16.41%)
      		12.4M
      LGHLWLion Group Holding Ltd
      $ 0.0075
      (15.38%)
      		21.05k
      RELIReliance Global Group Inc
      $ 0.52
      (-13.89%)
      		1.96M
      NTBLNotable Labs Ltd
      $ 0.67
      (-10.90%)
      		26.55k
      PBMPsyence Biomedical Ltd
      $ 0.5398
      (-10.03%)
      		8.9M
      SMXSMX Security Matters Public Company
      $ 0.1447
      (-10.01%)
      		2.27M
      LUXHLuxUrban Hotels Inc
      $ 0.265
      (-8.62%)
      		96.14k
      ZCARZoomcar Holdings Inc
      $ 0.16
      (9.44%)
      		13.92M
      KTRAKintara Therapeutics Inc
      $ 0.32
      (16.41%)
      		12.42M
      NVDANVIDIA Corporation
      $ 130.18
      (-0.46%)
      		12.19M
      SPECSpectaire Holdings Inc
      $ 1.01
      (197.06%)
      		9.17M
      PBMPsyence Biomedical Ltd
      $ 0.5398
      (-10.03%)
      		8.91M

      TNGX Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      TNGX under $10
      👍️0
      bikaver bikaver 9 months ago
      Stopped out with small loss.
      👍️0
      bikaver bikaver 10 months ago
      TNGX......Holding up well, but will tumble soon.
      👍️0
      bikaver bikaver 10 months ago
      TNGA.....short @ 8.60 This is the strength that I wanted to see!
      👍️0
      bikaver bikaver 10 months ago
      TNGX.....Studying the TNGX chart this evening. I'll short it at a good sign of strength if the opportunity presents itself tomorrow.
      👍️0
      SmokeSignals SmokeSignals 10 months ago
      up $4>H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
      Barclays Releases a Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
      Goldman Sachs Keeps Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 7, 2023TIPRANKS
      Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business HighlightsAUGUST 7, 2023TIPRANKS
      Tango Therapeutics reports Q2 EPS (23c), consensus (34c)AUGUST 7, 2023TIPRANKS
      👍️0

      Your Recent History

      NASDAQ
      TNGX
      Tango Therapeutics
      NASDAQ
      GXAI
      Gaxos ai
      Delayed Upgrade Clock